Spyre Therapeutics Overview

Spyre Therapeutics Operating Income

Operating Income for SYRE.

Quarterly Operating Income

$-75641000.00

↑ 41.21% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-241636000.00

↑ 12.72% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin